Drug desensitization in allergic children.

Area of Science:

• Clinical immunology and allergy
• Pharmacology and therapeutics

Background:

• Drug allergy and hypersensitivity reactions are increasing global health concerns.
• Novel targeted therapies for malignancies and chronic inflammatory diseases present challenges when hypersensitivity occurs.
• Lack of suitable alternative drugs necessitates alternative management strategies.

Purpose of the Study:

• To highlight drug desensitization as a critical option for patients with hypersensitivity reactions.
• To underscore the importance of desensitization when alternative therapies are inferior or more toxic.
• To acknowledge the limited understanding of drug desensitization mechanisms.

Main Methods:

• Drug desensitization involves gradual dose escalation of the causative agent.
• Protocols require specialized training and multidisciplinary allergy teams (physicians, nurses, pharmacists).
• Standardized protocols are applicable to both pediatric and adult populations, with dose adjustments.

Main Results:

• Drug desensitization allows safe administration of drugs in patients with prior hypersensitivity.
• The procedure is clinically successful, offering a viable option when alternatives are unavailable or suboptimal.
• No fundamental differences exist in desensitization protocols between children and adults, barring final cumulative dose.

Conclusions:

• Drug desensitization is an essential intervention for managing drug hypersensitivity when necessary.
• Further research into the mechanisms and molecular targets of drug desensitization is warranted.
• Multidisciplinary team collaboration is key to successful desensitization implementation.